Gregory T. Carter
About
In The Last Decade
Gregory T. Carter
126 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 138
- Neurology 960
- Molecular Biology 920
- Pharmacology 803
- Cellular and Molecular Neuroscience 795
- Physiology 583
Countries citing papers authored by Gregory T. Carter
This map shows the geographic impact of Gregory T. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory T. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory T. Carter more than expected).
Fields of papers citing papers by Gregory T. Carter
This network shows the impact of papers produced by Gregory T. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory T. Carter. The network helps show where Gregory T. Carter may publish in the future.
Co-authorship network of co-authors of Gregory T. Carter
This figure shows the co-authorship network connecting the top 25 collaborators of Gregory T. Carter. A scholar is included among the top collaborators of Gregory T. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory T. Carter. Gregory T. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Amyotrophic Lateral Sclerosis, the Endocannabinoid System, and Exogenous Cannabinoids: Current State and Clinical Implications | Muscle & Nerve | Travis T. Denton, Gregory T. Carter et al. | 0 |
| 2 | ALSUntangled #66: antimycobacterial antibiotics. | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Ellen S. Pierce, Paul E. Barkhaus et al. | 1 |
| 3 | Rehabilitation Management in Neuromuscular Disease | Gregory T. Carter | 4 | |
| 4 | Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State | Journal of Opioid Management | Sunil Aggarwal, Gregory T. Carter et al. | 29 |
| 5 | Pilot Randomized Trial Comparing Intersession Scheduling of Biofeedback Results to Individuals with Chronic Pain | American Journal of Physical Medicine & Rehabilitation | Douglas L. Weeks, Gregory T. Carter et al. | 14 |
| 6 | Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy | Human Molecular Genetics | Ewa Stępniak-Konieczna, Jessica Wei et al. | 42 |
| 7 | Charcot‐Marie‐Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies | PM&R | John D. England, Gregory T. Carter et al. | 32 |
| 8 | Pediatric Rehabilitation | Physical Medicine and Rehabilitation Clinics of North America | Gregory T. Carter | 0 |
| 9 | Electrodiagnosis in Persons With Amyotrophic Lateral Sclerosis | PM&R | Nanette C. Joyce, Gregory T. Carter | 43 |
| 10 | Symptom Burden in Persons with Myotonic and Facioscapulohumeral Muscular Dystrophy | American Journal of Physical Medicine & Rehabilitation | Amanda Smith, Kara McMullen et al. | 19 |
| 11 | Disease Burden in Neuromuscular Disease | Physical Medicine and Rehabilitation Clinics of North America | Gregory T. Carter, Jordi Miró et al. | 14 |
| 12 | Skeletal Muscle Edema in Muscular Dystrophy: Clinical and Diagnostic Implications | Physical Medicine and Rehabilitation Clinics of North America | Sandra L. Poliachik, Seth D. Friedman et al. | 22 |
| 13 | Aging with Muscular Dystrophy: Pathophysiology and Clinical Management | Physical Medicine and Rehabilitation Clinics of North America | Gregory T. Carter, Michael D. Weiss et al. | 5 |
| 14 | The Amyotrophic Lateral Sclerosis Center: A Model of Multidisciplinary Management | Physical Medicine and Rehabilitation Clinics of North America | Michael D. Weiss, B. Jane Distad et al. | 27 |
| 15 | Clinical features of late‐onset Pompe disease: A prospective cohort study | Muscle & Nerve | John H. J. Wokke, Diana M. Escolar et al. | 132 |
| 16 | Physiological and Anatomical Basis of Muscle Magnetic Resonance Imaging | Physical Medicine and Rehabilitation Clinics of North America | Russell C. Fritz, Gregory T. Carter et al. | 7 |
| 17 | Chronic Pain in Persons with Neuromuscular Disease | Physical Medicine and Rehabilitation Clinics of North America | Amy J. Hoffman, Mark P. Jensen et al. | 27 |
| 18 | Electrodiagnostic evaluation of hereditary motor and sensory neuropathies | Physical Medicine and Rehabilitation Clinics of North America | Gregory T. Carter, John D. England et al. | 4 |
| 19 | Marijuana in the management of amyotrophic lateral sclerosis | American Journal of Hospice and Palliative Medicine® | Gregory T. Carter et al. | 40 |
| 20 | Pursed lips breathing improves ventilation in myotonic muscular dystrophy | Archives of Physical Medicine and Rehabilitation | Viviane Ugalde, Eileen Hanafin Breslin et al. | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.